← Browse by Condition

Medical Condition

dementia

Total Trials

29

Recruiting Now

29

Trial Phases

Phase 2, Phase 4

ClinicalMetric tracks all active clinical trials for dementia sourced from ClinicalTrials.gov. Research in this area spans early-phase safety investigations through large Phase 3 confirmatory trials, conducted by NIH-funded academic centers, independent investigators, and pharmaceutical sponsors worldwide. Each listing is updated daily as new studies open enrollment and existing ones reach capacity or complete follow-up.

Trial listings include the NCT identifier, current recruitment status, phase classification, primary and secondary endpoints, estimated enrollment size, participating countries, and direct links to the full protocol on ClinicalTrials.gov. Eligibility criteria — including age range, disease stage, and prior treatment requirements — are documented for every study to help patients and clinicians assess suitability before contacting a trial site.

Frequently Asked Questions — dementia Clinical Trials

How many clinical trials are currently recruiting for dementia?

ClinicalMetric currently tracks 29 actively recruiting clinical trials for dementia, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 29. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.

What trial phases are available for dementia?

dementia research spans Phase 2 (1 trial), Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.

How do I find out if I qualify for a dementia clinical trial?

Eligibility criteria for dementia trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.

Trial Phases

Phase 2

1

Phase 4

1

Top Sponsors

Johns Hopkins University 1 trial

Norwegian University of Science and Technology 1 trial

University of Utah 1 trial

HAII corp.ltd 1 trial

Alzheimer's Light LLC 1 trial

Recruiting Clinical Trials

HEARS-NPS: Addressing Hearing Loss as a Common Unmet Contributor of Neuropsychiatric Symptoms

Johns Hopkins University

Multimodal Assesment of Alzheimer Patients

Norwegian University of Scienc...

Financial Counseling for Dementia Family Caregivers in Early and Middle Adulthood

University of Utah

Confirmatory Clinical Trial for Verifying the Efficacy and Safety of 'ALZGUARD' as a Digital Dementia Diagnostic Aid-Tool for the Diagnosis of the Major Neurocognitive Disorders

Alzheimer's Disease Treatment With Combination of 40Hz Light and Cognitive Therapy

Alzheimer's Light LLC

Large Language Model for Understanding and Monitoring Elderly Neurocognition

Northumbria Healthcare NHS Fou...

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

Ewha Womans University Mokdong...

Clinical Risk Score Prediction for Risk of Dementia Among Late-life Population With Depression

Second Affiliated Hospital of ...

Alzheimer's Prevention Registry: A Program to Accelerate Enrollment Into Studies

Advances in Neuropsychological Diagnostics

Istituto Auxologico Italiano

Oriental Intervention for Enhanced Neurocognitive Health (ORIENT) Diet in Patients With Intracranial / Carotid Stenosis

Second Affiliated Hospital, Zh...

Neuropsychological Assessment Of The Oldest-Old Population.(NEUROPSIC-GR)

Consorci Sanitari de l'Alt Pen...

Study Protocol: The Efficacy of Mushroom to Reduce Cognitive Decline in At-Risk Middle-aged Adults and Young-olds Living in the Community

National University of Singapo...

SUNAM Protocol for Managing BPSD

Mackay Medical College

Tele-Savvy for Latino Caregivers

University of Rochester

Evaluating the Efficacy of the Pain Identification and Communication Toolkit

Weill Medical College of Corne...

The Immune Response to Stroke

University of Oslo

Effects of Step Training in Older Adults with Mild Dementia

The Hong Kong Polytechnic Univ...

Benefits of Personalised Music in Dementia - a Feasibility Study

Music for my Mind

Clinical Applications of Advanced Ophthalmic Imaging

University of Miami

Resilient Together for Dementia (RT-D)

Icahn School of Medicine at Mo...

Comprehensive Assessment of Neurodegeneration and Dementia

McGill University

DemensiaKITA Mobile Health App to Improve Knowledge, Attitude, Practice and Reduce Burden Among Dementia Caregivers in Malaysia

Universiti Teknologi Mara

NCT05582161 Phase 2

Efficacy Biomarkers of DAOIB for Dementia

Chang Gung Memorial Hospital

Neurofilament Light Chain And Voice Acoustic Analyses In Dementia Diagnosis

Monash University

NCT06093126 Phase 4

Lemborexant for Insomnia in a Patient With Dementia: An N-of-1 Trial

Nova Scotia Health Authority

Testing & Refinement of CarePair: An Assessment and Referral Platform to Support Family Caregivers of Alzheimer's Disease and Related Dementias.

University of Southern Califor...

Taiwan Geriatric Study for Dementia Risk Prevention and Cognitive Enhancement by Multi-modal Intervention

Taipei Medical University Shua...

Research on the Early and Prognosis Diagnosis of Vascular Dementia

National Taiwan University Hos...

Related Conditions

alzheimer disease (5) cognitive impairment (4) mild cognitive impairment (3) cognition disorders in old age (2) cognitive decline (2) subjective cognitive decline scd (2) caregiver burden (2) hearing loss (1) alzheimer disease late onset (1) family caregivers (1) financial wellbeing (1) financial coaching (1)

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology